Phenotypically, TNFR2+TNF− Tregs expressed higher levels of CD25 in the spleen, and of OX40 and CD71 in both spleen and tumor, compared with TNFR2−TNF+ Tregs. This evidence concerns the gene TFRC and neoplasm.